This is a routine notification of an upcoming earnings date. Traders should monitor the interim results release on July 30 for updates on revenue, pipeline progress, and guidance. The filing itself does not contain any material information that would move the stock.
HCM drugs
HCM drug pipeline →How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jun 30 $10.76entry
- T+1 · 5mo ago +0.19%α +0.32% · $10.78
- T+5 · 4mo ago +8.27%α +7.67% · $11.65
- T+20 · 4mo ago +3.35%α +4.37% · $11.12
- T+60 · 8w ago +33.55%α +30.73% · $14.37
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
HUTCHMED filed a Form 6-K announcing that it will release its 2026 half-year financial results on July 30, 2026, with webcasts for analysts and investors. No financial data or material business updates were provided in this filing.
Key Facts
- HUTCHMED will announce interim results for the six months ended June 30, 2026 on July 30, 2026.
- Two webcasts (English and Chinese) will be held to discuss the results.
- No financial figures or guidance were disclosed in this filing.
Financial Impact
No financial data provided in the filing.
Risk Factors
- No specific risks identified from this filing; risks will surface in the interim results.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001648257-26-000045 |
| Document: hcm-20260630xex99d1.htm | 0001648257-26-000045 |
| Document: 0001648257-26-000045-index-headers.html | 0001648257-26-000045 |
| Document: 0001648257-26-000045-index.html | 0001648257-26-000045 |
| Document: 0001648257-26-000045.txt | 0001648257-26-000045 |
Track record
33 reports on HCM
8 of 9 bullish or bearish reports moved the stock their way by T+60. Best: +38.35% at T+60 after the Jun 25, 2026 report. 18 of 23 went positive at some point.
Filters
- Nov 15, 20261d ago Press Release Neutral 4/10 Entry $14.90 Now $14.73 −1.14% settles Feb 12
- Nov 5, 202611d ago 6-K Bullish 5/10 Entry $14.20 Now $14.73 +3.73% settles Feb 3
- Nov 2, 202614d ago 6-K Bullish 6/10 Entry $13.27 Now $14.73 +11.00% settles Jan 29
- Nov 2, 202615d ago Press Release Bullish 6/10 Entry $13.08 Now $14.73 +12.61% settles Feb 1
- Oct 29, 202618d ago 6-K Neutral 4/10 Entry $13.59 Now $14.73 +8.39% settles Jan 27
- Oct 27, 202620d ago 6-K Neutral 2/10 Entry $13.80 Now $14.73 +6.74% settles Jan 25
- Oct 26, 202621d ago 6-K Bullish 6/10 Entry $14.27 Now $14.73 +3.22% settles Jan 22
- Oct 26, 202621d ago Press Release Bullish 7/10 Entry $14.27 Now $14.73 +3.22% settles Jan 22
- Oct 26, 202622d ago Press Release Bullish 7/10 Entry $13.80 Now $14.73 +6.74% settles Jan 25
- Oct 21, 202626d ago 6-K Bullish 7/10 Entry $14.37 Now $14.73 +2.51% settles Jan 19
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers